<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34756614</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2518</ISSN><JournalIssue CitedMedium="Internet"><Volume>41 Suppl 1</Volume><PubDate><Year>2023</Year><Month>Apr</Month><Day>06</Day></PubDate></JournalIssue><Title>Vaccine</Title><ISOAbbreviation>Vaccine</ISOAbbreviation></Journal><ArticleTitle>The immediate impact of the COVID-19 pandemic on polio immunization and surveillance activities.</ArticleTitle><Pagination><StartPage>A2</StartPage><EndPage>A11</EndPage><MedlinePgn>A2-A11</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2021.10.028</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0264-410X(21)01347-5</ELocationID><Abstract><AbstractText>In addition to affecting individual health the COVID-19 pandemic has disrupted efforts to deliver essential health services around the world. In this article we present an overview of the immediate programmatic and epidemiologic impact of the pandemic on polio eradication as well as the adaptive strategic and operational measures taken by the Global Polio Eradication Initiative (GPEI) from March through September 2020. Shortly after the World Health Organization (WHO) declared a global pandemic on 11 March 2020, the GPEI initially redirected the programme's assets to tackle COVID-19 and suspended house-to-house supplementary immunization activities (SIAs) while also striving to continue essential poliovirus surveillance functions. From March to May 2020, 28 countries suspended a total of 62 polio vaccine SIAs. In spite of efforts to continue poliovirus surveillance, global acute flaccid paralysis (AFP) cases reported from January-July 2020 declined by 34% compared with the same period in 2019 along with decreases in the mean number of environment samples collected per active site in the critical areas of the African and Eastern Mediterranean regions. The GPEI recommended countries should resume planning and implementation of SIAs starting in July 2020 and released guidelines to ensure these could be done safely for front line workers and communities. By the end of September 2020, a total of 14 countries had implemented circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreak response vaccination campaigns and Afghanistan and Pakistan restarted SIAs to stop ongoing wild poliovirus type 1 (WPV1) transmission. The longer-term impacts of disruptions to eradication efforts remain to be determined, especially in terms of the effect on poliovirus epidemiology. Adapting to the pandemic situation has imposed new considerations on program implementation and demonstrated not only GPEI's contribution to global health security, but also identified potential opportunities for coordinated approaches across immunization and health services.</AbstractText><CopyrightInformation>Copyright © 2021. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Burkholder</LastName><ForeName>Brent</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Global Public Health Consultant, 834 Miller Drive, Davis, CA 95616, United States. Electronic address: Burkholder834@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wadood</LastName><ForeName>Zubair</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>WHO Polio Eradication Division, Avenue Appia 20, 1211 Geneva, Switzerland. Electronic address: Wadoodm@who.int.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kassem</LastName><ForeName>Ahmed M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Global Immunization Division, US Centers for Disease Control and Prevention, 1600 Clifton Road, NE Atlanta, GA 30333, United States. Electronic address: Yxo5@cdc.gov.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ehrhardt</LastName><ForeName>Derek</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Global Immunization Division, US Centers for Disease Control and Prevention, 1600 Clifton Road, NE Atlanta, GA 30333, United States. Electronic address: Fev1@cdc.gov.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zomahoun</LastName><ForeName>Delayo</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>WHO Polio Eradication Division, Avenue Appia 20, 1211 Geneva, Switzerland. Electronic address: dzomahoun@who.int.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>001</GrantID><Acronym>WHO_</Acronym><Agency>World Health Organization</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Vaccine</MedlineTA><NlmUniqueID>8406899</NlmUniqueID><ISSNLinking>0264-410X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060740" MajorTopicYN="N">Disease Eradication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="N">Poliovirus Vaccine, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017589" MajorTopicYN="N">Immunization Programs</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Circulating vaccine-derived poliovirus</Keyword><Keyword MajorTopicYN="N">Global polio eradication</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>10</Day><Hour>14</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>10</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34756614</ArticleId><ArticleId IdType="pmc">PMC8531002</ArticleId><ArticleId IdType="doi">10.1016/j.vaccine.2021.10.028</ArticleId><ArticleId IdType="pii">S0264-410X(21)01347-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chard AN, Datta SD, Tallis G, et al. Progress Toward Polio Eradication — Worldwide, January 2018– March 2020. MMWR Morb Mortal Wkly Rep 2020; 69:784–789. http://dx.doi.org/10.15585/mmwr.mm6925a4, [accessed 11 March 2021].</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7316320</ArticleId><ArticleId IdType="pubmed">32584798</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO COVID-19 Dashboard. https://covid19.who.int/, [accessed 17 September 2021]; and John Hopkins Corona Virus Resource Center, https://coronavirus.jhu.edu/ , [accessed 17 September 2021].</Citation></Reference><Reference><Citation>Several antibody surveys indicate the possibility of significant under-reporting of cases in Africa. See Nordling L et al. Africa's pandemic puzzle: why so few cases and deaths? Science. 14 Aug 2020: Vol. 369, Issue 6505, pp. 756-757. doi: 10.1126/science.369.6505.756</Citation><ArticleIdList><ArticleId IdType="pubmed">32792376</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Regional Office for Africa, Corona virus dashboard. https://who.maps.arcgis.com/apps/opsdashboard/index.html#/0c9b3a8b68d0437a8cf28581e9c063a9, [accessed 11 March 2021].</Citation></Reference><Reference><Citation>WHO Regional Office for Eastern Mediterranean, Corona virus dashboard. http://www.emro.who.int/health-topics/corona-virus/index.html , [accessed 11 March 2021].</Citation></Reference><Reference><Citation>Global Polio Eradication Initiative. Polio Eradication in the Context of the COVID-19 Pandemic: Summary of urgent country and regional recommendations from the Polio Oversight Board meeting of March 24, 2020, www.polioeradication.org, [accessed 11 March 2021].</Citation></Reference><Reference><Citation>World Health Organization. Immunization as an essential health service: guiding principles for immunization activities during the COVID-19 pandemic and other times of severe disruption, https://cms.who.int/publications/i/item/immunization-as-an-essential-health-service-guiding-principles-for-immunization-activities-during-the-covid-19-pandemic-and-other-times-of-severe-disruption#, [accessed 11 March 2021].</Citation></Reference><Reference><Citation>Global Polio Eradication Initiative. Polio Eradication Programme Continuity: implementation in the context of COVID-19 pandemic - Interim guide 25 March 2020, https://polioeradication.org/news-post/global-polio-eradication-and-covid-19/, [accessed 11 March 2021].</Citation></Reference><Reference><Citation>World Health Organization. Polio network contributions to COVID-19: Turning the Challenge into an Opportunity for Polio Transition, https://apps.who.int/iris/bitstream/handle/10665/336261/9789240011533-eng.pdf?sequence=1&amp;isAllowed=y, [accessed 11 March 2021].</Citation></Reference><Reference><Citation>Zomahoun D.J., Burman A.L., Snider C.J., et al. Impact of COVID-19 Pandemic on Global Poliovirus Surveillance. MMWR Morb Mortal Wkly Rep. 2021;2021(69):1648–1652. doi: 10.15585/mmwr.mm695152a4. accessed 11 March.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm695152a4</ArticleId><ArticleId IdType="pmc">PMC9191906</ArticleId><ArticleId IdType="pubmed">33382673</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Polio Eradication Initiative Polio Information System (POLIS). https://extranet.who.int/polis/ [accessed 17 September 2021].</Citation></Reference><Reference><Citation>World Health Organization. Immunization Repository: Campaign Delay tracker. https://www.who-immunization-repository.org/, [accessed 17 September 2021].</Citation></Reference><Reference><Citation>World Health Organization. Pulse survey on continuity of essential health services during the COVID-19 pandemic: interim report, 27 August 2020. https://www.who.int/publications/i/item/WHO-2019-nCoV-EHS_continuity-survey-2020.1, [accessed 11 March2021].</Citation></Reference><Reference><Citation>Masresha Balcha Girma, et al. The performance of routine immunization in selected African countries during the first six months of the COVID-19 pandemic. Pan African Medical Journal. 2020;37(1):12. doi: 10.11604/pamj.supp.2020.37.1.26107.</Citation><ArticleIdList><ArticleId IdType="doi">10.11604/pamj.supp.2020.37.1.26107</ArticleId><ArticleId IdType="pmc">PMC7733346</ArticleId><ArticleId IdType="pubmed">33343791</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandir S., Siddiqui D.A., Mehmood M., et al. Impact of COVID-19 pandemic response on uptake of routine immunization in Sindh, Pakistan: An analysis of provincial electronic immunization registry data. Vaccine. 2020 Oct 21;38(45):7146–7155. doi: 10.1016/j.vaccine.2020.08.019. PMCID: PMC7428732. Published online 2020 Aug 15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2020.08.019</ArticleId><ArticleId IdType="pmc">PMC7428732</ArticleId><ArticleId IdType="pubmed">32943265</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Polio Eradication Initiative. Update on modelling of impact of pause in polio eradication activities. Presentation to the Strategic Advisory Group of Experts on Immunization Polio Working Group, 1 September 2020. [Unpublished]</Citation></Reference><Reference><Citation>Voorman A, et al. Real-time prediction model of cVDPV2 outbreaks to aid outbreak response vaccination strategies. In press.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10109086</ArticleId><ArticleId IdType="pubmed">34483024</ArticleId></ArticleIdList></Reference><Reference><Citation>Molodecky N, et al. Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemic. In press.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8463303</ArticleId><ArticleId IdType="pubmed">34629206</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalkowska DA, et al. The impact of disruptions caused by the COVID-19 pandemic on global polio eradication. In press.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10045205</ArticleId><ArticleId IdType="pubmed">33962838</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey, K., Hagedorn, B., McCarthy, K.A., et al. The risk of SARS-CoV-2 transmission to communities and to health workers in LMICs under various health service delivery conditions; in report of WHO Immunization and vaccines related implementation research advisory committee, September 2020. https://terrance.who.int/mediacentre/data/sage/IVIR-AC_Pink_Book_sept_2020.pdf, [accessed 11 March 2021].</Citation></Reference><Reference><Citation>Global Polio Eradication Initiative. Polio Presentation Overview, Epidemiologic Week 14, 2020. [Unpublished].</Citation></Reference><Reference><Citation>Global Polio Eradication Initiative. Polio Presentation Overview, Epidemiologic Week 40, 2020. [Unpublished].</Citation></Reference><Reference><Citation>Global Polio Eradication Initiative. Polio Eradication in the context of the COVID-19 Pandemic - Updated urgent country and regional recommendations, 21 May 2020. http://polioeradication.org/wp-content/uploads/2020/03/updated-POB-country-and-regional-recommendations-20200526.pdf, [accessed 11 March 2021].</Citation></Reference><Reference><Citation>World Health Organization. Framework for decision-making: implementation of mass vaccination campaigns in the context of COVID-19, 20 May 2020. https://www.who.int/publications/i/item/WHO-2019-nCoV-Framework_Mass_Vaccination-2020.1, [accessed 11 March 2021].</Citation></Reference><Reference><Citation>Global Polio Eradication Initiative / World Health Organization. Interim guidance for the poliomyelitis (polio) surveillance network in the context of coronavirus disease (COVID-19), 14 May 2020. http://polioeradication.org/wp-content/uploads/2020/06/Interim-Guidance-Polio-Surveillance-in-the-context-of-COVID19-20200514.pdf, [accessed 11 March 2021].</Citation></Reference><Reference><Citation>Global Polio Eradication Initiative. Interim guidelines for frontline workers on safe implementation of house-to-house vaccination campaigns in the context of COVID-19. http://polioeradication.org/wp-content/uploads/2020/03/Interim-guidelines-for-frontline-workers-on-safe-implementation-of-house-to-house-vaccination-campaigns.pdf, [accessed 02 November 2020]. GPEI also released additional guidance to address the specific circumstances in Afghanistan and Pakistan: Operational guide for resuming SIAs during the CIVID-19 pandemic. V1.1, July 2020. [Unpublished].</Citation></Reference><Reference><Citation>Dr. Vachagan Harutyunyan, WHO Polio Department. [Personal communication]</Citation></Reference><Reference><Citation>World Health Organization. Maintaining essential health services: operational guidance for the COVID-19 context interim guidance - 1 June 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/related-health-issues, [accessed 11 March 2021].</Citation></Reference><Reference><Citation>Bhatnagar B and Gittelman D. Technical brief for the Health Campaign Effectiveness Coalition: Integration between health campaigns: intervention co-delivery and collaboration. July 2020. https://campaigneffectiveness.org/ , [accessed 11 March 2021].</Citation></Reference><Reference><Citation>World Health Organization. Second round of the national pulse survey on continuity of essential health services during the COVID-19 pandemic: January-March 2021: interim report, 22 April 2021. https://apps.who.int/iris/handle/10665/340937, [accessed 17 September 2021].</Citation></Reference><Reference><Citation>World Health Organization. Leave No One Behind: Guidance for Planning and Implementing Catch-up Vaccination, August 2020. https://www.paho.org/en/documents/who-leave-no-one-behind-guidance-planning-and-implementing-catch-vaccination-august-2020, [accessed 11 March 2021].</Citation></Reference><Reference><Citation>Global Polio Eradication Initiative. cVDPV Outbreaks &amp; vaccine deployment. Presentation to the Independent Monitoring Board, 17 November 2020. [Unpublished].</Citation></Reference><Reference><Citation>Global Polio Eradication Initiative. The Global Polio Program’s Successes and Remaining Challenges. Presentation to the Independent Monitoring Board, 17 November 2020. [Unpublished].</Citation></Reference><Reference><Citation>Global Polio Eradication Initiative Polio Information System (POLIS). Epi Overview. https://extranet.who.int/polis/Dashboard/Old [accessed 17 September 2021].</Citation></Reference><Reference><Citation>Global Polio Eradication Initiative. Delivering on a promise: polio eradication strategy 2022-26. https://polioeradication.org/gpei-strategy-2022-2026/ [accessed 17 September 2021].</Citation></Reference><Reference><Citation>WHO/UNICEF. Progress and challenges in sustaining and advancing immunization coverage during the COVID-19 pandemic. https://www.who.int/teams/immunization-vaccines-and-biologicals/immunization-analysis-and-insights/global-monitoring/immunization-coverage/who-unicef-estimates-of-national-immunization-coverage [accessed 17 September 2021].</Citation></Reference><Reference><Citation>Global Polio Eradication Initiative. Interim Programme of Work for Integrated Actions in the context of the COVID-19 Pandemic - September 2020. http://polioeradication.org/wp-content/uploads/2020/09/Integration-POW-under-Covid-v2.0.pdf [accessed 11 March 2021].</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>